59/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0. Gray context columns never affect the score. CEO quarterly pay is the explicitly marked annual ÷ 4 estimate.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly. Unavailable evidence scores 0 only in Win/Lose columns; gray columns award no points.
| Quarter | Total return | Revenue growth | EPS growth | Net marginNon-scoring | Trailing P/ENon-scoring | Price/bookNon-scoring | CEO quarterly payNon-scoring | Implied DilutionNon-scoring | Implied BuybackNon-scoring |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q21/3 |
LoseINFU / S&P 4.55% / 15.20% |
LoseINFU / S&P 2.47% / 15.00% |
WinINFU / S&P 73.91% / 50.40% |
Non-scoringINFU / S&P 5.96% / 15.70% | Non-scoringINFU / S&P 22.49 / 28.47 | Non-scoringINFU / S&P 3.25 / S&P unavailable | Non-scoringINFU / S&P INFU unavailable / S&P unavailable | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.36b |
| 2026-Q12/3 |
WinINFU / S&P 2.90% / -4.33% |
LoseINFU / S&P 3.50% / 11.30% |
WinINFU / S&P 164.29% / 27.70% |
Non-scoringINFU / S&P 5.56% / 14.80% | Non-scoringINFU / S&P 23.54 / 25.43 | Non-scoringINFU / S&P 3.17 / S&P unavailable | Non-scoringINFU / S&P INFU unavailable / S&P unavailable | Non-scoringINFU / S&P INFU unavailable / $0.27b | Non-scoringINFU / S&P INFU unavailable / $0.00b |
| 2025-Q41/3 |
LoseINFU / S&P -13.42% / 2.65% |
LoseINFU / S&P 6.36% / 9.00% |
WinINFU / S&P 210.00% / 13.40% |
Non-scoringINFU / S&P 4.62% / 13.20% | Non-scoringINFU / S&P 27.35 / 28.48 | Non-scoringINFU / S&P 3.16 / 5.39 | Non-scoringINFU / S&P INFU unavailable / $4.42m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.20b |
| 2025-Q33/3 |
WinINFU / S&P 66.03% / 8.12% |
WinINFU / S&P 6.23% / 4.61% |
WinINFU / S&P 333.33% / 13.45% |
Non-scoringINFU / S&P 3.92% / 11.78% | Non-scoringINFU / S&P 38.12 / 28.13 | Non-scoringINFU / S&P 3.80 / 5.27 | Non-scoringINFU / S&P INFU unavailable / $4.42m | Non-scoringINFU / S&P INFU unavailable / $0.11b | Non-scoringINFU / S&P INFU unavailable / $0.00b |
| 2025-Q23/3 |
WinINFU / S&P 15.99% / 10.94% |
WinINFU / S&P 8.13% / 4.83% |
WinINFU / S&P 2200.00% / 10.63% |
Non-scoringINFU / S&P 3.63% / 11.45% | Non-scoringINFU / S&P 25.13 / 27.10 | Non-scoringINFU / S&P 2.34 / 5.01 | Non-scoringINFU / S&P INFU unavailable / $4.42m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.23b |
| 2025-Q11/3 |
LoseINFU / S&P -36.33% / -4.27% |
WinINFU / S&P 7.98% / 4.98% |
LoseINFU / S&P INFU unavailable / 10.57% |
Non-scoringINFU / S&P 2.32% / 11.39% | Non-scoringINFU / S&P 35.37 / 26.23 | Non-scoringINFU / S&P 2.05 / 4.69 | Non-scoringINFU / S&P INFU unavailable / $4.42m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.10b |
| 2024-Q43/3 |
WinINFU / S&P 26.12% / 2.41% |
WinINFU / S&P 7.22% / 5.25% |
WinINFU / S&P 233.33% / 6.15% |
Non-scoringINFU / S&P 1.74% / 11.29% | Non-scoringINFU / S&P 76.65 / 28.60 | Non-scoringINFU / S&P 3.12 / 4.99 | Non-scoringINFU / S&P INFU unavailable / $4.28m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.08b |
| 2024-Q32/3 |
LoseINFU / S&P -1.90% / 5.89% |
WinINFU / S&P 8.09% / 5.89% |
WinINFU / S&P 100.00% / 6.11% |
Non-scoringINFU / S&P 1.12% / 10.87% | Non-scoringINFU / S&P 95.87 / 28.09 | Non-scoringINFU / S&P 2.56 / 4.94 | Non-scoringINFU / S&P INFU unavailable / $4.28m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.21b |
| 2024-Q21/3 |
LoseINFU / S&P -20.30% / 4.28% |
WinINFU / S&P 9.44% / 5.38% |
LoseINFU / S&P -50.00% / 5.12% |
Non-scoringINFU / S&P 0.28% / 10.85% | Non-scoringINFU / S&P 397.76 / 27.64 | Non-scoringINFU / S&P 2.72 / 4.79 | Non-scoringINFU / S&P INFU unavailable / $4.28m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.36b |
| 2024-Q11/3 |
LoseINFU / S&P -18.69% / 10.56% |
WinINFU / S&P 12.23% / 5.71% |
LoseINFU / S&P -100.00% / 5.59% |
Non-scoringINFU / S&P 0.07% / 10.81% | Non-scoringINFU / S&P 2172.11 / 27.02 | Non-scoringINFU / S&P 3.49 / 4.71 | Non-scoringINFU / S&P INFU unavailable / $4.28m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.12b |
| 2023-Q41/3 |
LoseINFU / S&P 9.34% / 11.69% |
WinINFU / S&P 14.44% / 6.81% |
LoseINFU / S&P -400.00% / 7.78% |
Non-scoringINFU / S&P 0.69% / 11.19% | Non-scoringINFU / S&P 256.21 / 24.35 | Non-scoringINFU / S&P 4.27 / 4.31 | Non-scoringINFU / S&P INFU unavailable / $4.08m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.01b |
| 2023-Q32/3 |
WinINFU / S&P 0.10% / -3.27% |
WinINFU / S&P 14.16% / 7.52% |
LoseINFU / S&P -864691128455135360.00% / -5.03% |
Non-scoringINFU / S&P 0.74% / 10.84% | Non-scoringINFU / S&P 225.15 / 23.93 | Non-scoringINFU / S&P 3.97 / 3.98 | Non-scoringINFU / S&P INFU unavailable / $4.08m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.24b |
| 2023-Q22/3 |
WinINFU / S&P 24.26% / 8.74% |
WinINFU / S&P 10.59% / 9.50% |
LoseINFU / S&P -150.00% / -8.57% |
Non-scoringINFU / S&P 0.56% / 10.88% | Non-scoringINFU / S&P 306.69 / 24.01 | Non-scoringINFU / S&P 4.06 / 4.19 | Non-scoringINFU / S&P INFU unavailable / $4.08m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.17b |
| 2023-Q10/3 |
LoseINFU / S&P -10.71% / 7.50% |
LoseINFU / S&P 8.44% / 10.77% |
LoseINFU / S&P -200.00% / -15.69% |
Non-scoringINFU / S&P 0.05% / 10.82% | Non-scoringINFU / S&P 2616.39 / 22.66 | Non-scoringINFU / S&P 3.36 / 3.93 | Non-scoringINFU / S&P INFU unavailable / $4.08m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.13b |
| 2022-Q41/3 |
WinINFU / S&P 24.18% / 7.56% |
LoseINFU / S&P 7.36% / 11.88% |
LoseINFU / S&P -116.67% / -17.99% |
Non-scoringINFU / S&P 0.02% / 11.09% | Non-scoringINFU / S&P 10021.53 / 22.65 | Non-scoringINFU / S&P 3.76 / 3.75 | Non-scoringINFU / S&P INFU unavailable / $3.70m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.15b |
| 2022-Q30/3 |
LoseINFU / S&P -27.41% / -4.88% |
LoseINFU / S&P 6.99% / 13.47% |
LoseINFU / S&P -100.00% / -1.41% |
Non-scoringINFU / S&P 0.28% / 12.28% | Non-scoringINFU / S&P 484.84 / 20.58 | Non-scoringINFU / S&P 3.02 / 3.60 | Non-scoringINFU / S&P INFU unavailable / $3.70m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.17b |
| 2022-Q21/3 |
WinINFU / S&P -1.73% / -16.10% |
LoseINFU / S&P 7.82% / 13.71% |
LoseINFU / S&P -105.71% / 11.04% |
Non-scoringINFU / S&P -0.55% / 13.03% | Non-scoringINFU / S&P INFU unavailable / 20.28 | Non-scoringINFU / S&P 4.29 / 3.78 | Non-scoringINFU / S&P INFU unavailable / $3.70m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.17b |
| 2022-Q10/3 |
LoseINFU / S&P -42.45% / -4.60% |
LoseINFU / S&P 4.37% / 15.97% |
LoseINFU / S&P -98.82% / 42.23% |
Non-scoringINFU / S&P 0.37% / 14.22% | Non-scoringINFU / S&P 514.82 / 22.19 | Non-scoringINFU / S&P 4.37 / 4.51 | Non-scoringINFU / S&P INFU unavailable / $3.70m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.20b |
| 2021-Q41/3 |
WinINFU / S&P 30.70% / 11.03% |
LoseINFU / S&P 5.13% / 15.00% |
LoseINFU / S&P -92.50% / 96.40% |
Non-scoringINFU / S&P 1.39% / 15.13% | Non-scoringINFU / S&P 248.25 / 23.63 | Non-scoringINFU / S&P 7.30 / 4.73 | Non-scoringINFU / S&P INFU unavailable / $3.63m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.13b |
| 2021-Q30/3 |
LoseINFU / S&P -37.33% / 0.58% |
LoseINFU / S&P 6.55% / 10.77% |
LoseINFU / S&P 54.29% / 69.42% |
Non-scoringINFU / S&P 11.64% / 14.13% | Non-scoringINFU / S&P 22.94 / 25.35 | Non-scoringINFU / S&P 5.78 / 4.38 | Non-scoringINFU / S&P INFU unavailable / $3.63m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.19b |
| 2021-Q22/3 |
LoseINFU / S&P 2.11% / 8.55% |
WinINFU / S&P 9.24% / 6.58% |
WinINFU / S&P 169.23% / 51.81% |
Non-scoringINFU / S&P 15.22% / 13.34% | Non-scoringINFU / S&P 28.33 / 26.70 | Non-scoringINFU / S&P 9.57 / 4.43 | Non-scoringINFU / S&P INFU unavailable / $3.63m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.11b |
| 2021-Q13/3 |
WinINFU / S&P 8.41% / 6.17% |
WinINFU / S&P 18.73% / -1.06% |
WinINFU / S&P 844.44% / 7.39% |
Non-scoringINFU / S&P 18.36% / 11.60% | Non-scoringINFU / S&P 22.56 / 30.50 | Non-scoringINFU / S&P 9.67 / 4.23 | Non-scoringINFU / S&P INFU unavailable / $3.63m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.10b |
| 2020-Q43/3 |
WinINFU / S&P 46.49% / 12.15% |
WinINFU / S&P 20.06% / -3.72% |
WinINFU / S&P 1233.33% / -33.42% |
Non-scoringINFU / S&P 17.80% / 8.86% | Non-scoringINFU / S&P 21.99 / 39.26 | Non-scoringINFU / S&P 9.35 / 4.05 | Non-scoringINFU / S&P INFU unavailable / $3.17m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.01b |
| 2020-Q33/3 |
WinINFU / S&P 11.09% / 8.93% |
WinINFU / S&P 50.71% / -2.04% |
WinINFU / S&P 3400.00% / -27.10% |
Non-scoringINFU / S&P 7.91% / 9.24% | Non-scoringINFU / S&P 34.74 / 34.27 | Non-scoringINFU / S&P 8.83 / 3.65 | Non-scoringINFU / S&P INFU unavailable / $3.17m | Non-scoringINFU / S&P INFU unavailable / $0.02b | Non-scoringINFU / S&P INFU unavailable / $0.00b |
| 2020-Q22/3 |
WinINFU / S&P 35.92% / 20.54% |
WinINFU / S&P 106.04% / -0.46% |
LoseINFU / S&P -471.43% / -27.11% |
Non-scoringINFU / S&P 6.24% / 9.37% | Non-scoringINFU / S&P 41.03 / 31.29 | Non-scoringINFU / S&P 8.87 / 3.44 | Non-scoringINFU / S&P INFU unavailable / $3.17m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.03b |
| 2020-Q12/3 |
WinINFU / S&P -0.47% / -19.60% |
WinINFU / S&P 216.56% / 3.47% |
LoseINFU / S&P -181.82% / -14.75% |
Non-scoringINFU / S&P 2.25% / 10.68% | Non-scoringINFU / S&P 89.34 / 22.80 | Non-scoringINFU / S&P 7.72 / 2.92 | Non-scoringINFU / S&P INFU unavailable / $3.17m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.05b |
| 2019-Q42/3 |
WinINFU / S&P 61.25% / 9.07% |
WinINFU / S&P 668.57% / 5.36% |
LoseINFU / S&P -220.00% / 2.99% |
Non-scoringINFU / S&P 1.68% / 12.81% | Non-scoringINFU / S&P 124.61 / 22.78 | Non-scoringINFU / S&P 7.59 / 3.53 | Non-scoringINFU / S&P INFU unavailable / $3.08m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.05b |
| 2019-Q32/3 |
WinINFU / S&P 23.02% / 1.70% |
WinINFU / S&P 504.25% / 5.02% |
LoseINFU / S&P -101.20% / 0.21% |
Non-scoringINFU / S&P 0.45% / 12.41% | Non-scoringINFU / S&P 373.46 / 22.44 | Non-scoringINFU / S&P 4.83 / 3.30 | Non-scoringINFU / S&P INFU unavailable / $3.08m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.09b |
| 2019-Q21/3 |
LoseINFU / S&P -14.17% / 4.30% |
WinINFU / S&P 352.81% / 6.64% |
LoseINFU / S&P -91.36% / 8.65% |
Non-scoringINFU / S&P -3.12% / 12.79% | Non-scoringINFU / S&P INFU unavailable / 21.37 | Non-scoringINFU / S&P 4.19 / 3.32 | Non-scoringINFU / S&P INFU unavailable / $3.08m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.27b |
| 2019-Q12/3 |
WinINFU / S&P 45.64% / 13.65% |
WinINFU / S&P 179.80% / 8.12% |
LoseINFU / S&P -86.90% / 14.29% |
Non-scoringINFU / S&P -8.47% / 12.97% | Non-scoringINFU / S&P INFU unavailable / 20.86 | Non-scoringINFU / S&P 5.00 / 3.26 | Non-scoringINFU / S&P INFU unavailable / $3.08m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $34.35b |
| 2018-Q41/3 |
WinINFU / S&P 5.85% / -13.52% |
LoseINFU / S&P 5.62% / 9.05% |
LoseINFU / S&P -94.57% / 18.23% |
Non-scoringINFU / S&P -10.38% / 13.10% | Non-scoringINFU / S&P INFU unavailable / 19.39 | Non-scoringINFU / S&P 3.29 / 2.94 | Non-scoringINFU / S&P INFU unavailable / $3.00m | Non-scoringINFU / S&P INFU unavailable / $0.01b | Non-scoringINFU / S&P INFU unavailable / $0.00b |
| 2018-Q31/3 |
LoseINFU / S&P -8.45% / 7.71% |
LoseINFU / S&P -56.47% / 10.21% |
WinINFU / S&P 453.33% / 19.06% |
Non-scoringINFU / S&P -181.51% / 13.01% | Non-scoringINFU / S&P INFU unavailable / 22.25 | Non-scoringINFU / S&P 3.09 / 3.45 | Non-scoringINFU / S&P INFU unavailable / $3.00m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.17b |
| 2018-Q22/3 |
WinINFU / S&P 22.41% / 3.43% |
LoseINFU / S&P -74.91% / 9.03% |
WinINFU / S&P 478.57% / 14.46% |
Non-scoringINFU / S&P -189.41% / 12.56% | Non-scoringINFU / S&P INFU unavailable / 22.49 | Non-scoringINFU / S&P 2.69 / 3.25 | Non-scoringINFU / S&P INFU unavailable / $3.00m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.19b |
| 2018-Q12/3 |
WinINFU / S&P 26.09% / -0.76% |
LoseINFU / S&P -82.57% / 7.68% |
WinINFU / S&P 950.00% / 12.46% |
Non-scoringINFU / S&P -199.49% / 12.27% | Non-scoringINFU / S&P INFU unavailable / 23.41 | Non-scoringINFU / S&P 2.11 / 3.17 | Non-scoringINFU / S&P INFU unavailable / $3.00m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.08b |
| 2017-Q42/3 |
WinINFU / S&P 12.20% / 6.64% |
LoseINFU / S&P -85.83% / 7.03% |
WinINFU / S&P 9100.00% / 13.82% |
Non-scoringINFU / S&P -207.24% / 12.09% | Non-scoringINFU / S&P INFU unavailable / 24.25 | Non-scoringINFU / S&P 1.69 / 3.23 | Non-scoringINFU / S&P INFU unavailable / $2.92m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.05b |
| 2017-Q31/3 |
WinINFU / S&P 17.14% / 4.48% |
LoseINFU / S&P -67.11% / 5.68% |
LoseINFU / S&P -314.29% / 17.57% |
Non-scoringINFU / S&P -13.38% / 12.04% | Non-scoringINFU / S&P INFU unavailable / 23.28 | Non-scoringINFU / S&P 0.96 / 3.08 | Non-scoringINFU / S&P INFU unavailable / $2.92m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.11b |
| 2017-Q20/3 |
LoseINFU / S&P -23.91% / 3.09% |
LoseINFU / S&P -47.23% / 4.83% |
LoseINFU / S&P -216.67% / 17.74% |
Non-scoringINFU / S&P -7.74% / 11.96% | Non-scoringINFU / S&P INFU unavailable / 23.40 | Non-scoringINFU / S&P 0.82 / 3.03 | Non-scoringINFU / S&P INFU unavailable / $2.92m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.08b |
| 2017-Q10/3 |
LoseINFU / S&P -9.80% / 6.07% |
LoseINFU / S&P -24.54% / 3.67% |
LoseINFU / S&P -157.14% / 13.32% |
Non-scoringINFU / S&P -3.18% / 11.75% | Non-scoringINFU / S&P INFU unavailable / 23.60 | Non-scoringINFU / S&P 1.05 / 3.01 | Non-scoringINFU / S&P INFU unavailable / $2.92m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $20.24b |
| 2016-Q40/3 |
LoseINFU / S&P -8.27% / 3.82% |
LoseINFU / S&P -0.64% / 2.09% |
LoseINFU / S&P -108.33% / 7.05% |
Non-scoringINFU / S&P -0.31% / 11.37% | Non-scoringINFU / S&P INFU unavailable / 23.76 | Non-scoringINFU / S&P 1.14 / 2.91 | Non-scoringINFU / S&P INFU unavailable / $2.88m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $1.11b |
| 2016-Q32/3 |
WinINFU / S&P 6.92% / 3.85% |
WinINFU / S&P 5.72% / 0.20% |
LoseINFU / S&P -36.36% / -3.15% |
Non-scoringINFU / S&P 2.45% / 10.82% | Non-scoringINFU / S&P 35.45 / 24.22 | Non-scoringINFU / S&P 1.23 / 2.78 | Non-scoringINFU / S&P INFU unavailable / $2.88m | Non-scoringINFU / S&P INFU unavailable / $0.00b | Non-scoringINFU / S&P INFU unavailable / $0.16b |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | INFU total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 11.87% | 20.78% |
| Annualized return | 11.87% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | INFU total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -16.31% | 83.14% |
| Annualized return | -3.50% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | INFU total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 323.16% | 319.30% |
| Annualized return | 15.52% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
- Net margin, P/E, P/B and other gray context columns never enter the score.
Snapshot captured 2026-09-04.